FHA
ANIP icon

First Horizon Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

First Horizon Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-160
Closed -$10.7K – 2324
2025
Q1 		$10.7K Buy
+160
New +$9.56K ﹤0.01% 1576
2024
Q4 		– Sell
-142
Closed -$8.47K – 2276
2024
Q3 		$8.47K Hold
142
– – ﹤0.01% 1663
2024
Q2 		$9.04K Hold
142
– – ﹤0.01% 1570
2024
Q1 		$9.82K Buy
+142
New +$8.57K ﹤0.01% 1587
2023
Q4 		– Sell
-146
Closed -$8.48K – 2365
2023
Q3 		$8.48K Sell
146
-33
-18% -$1.9K ﹤0.01% 1581
2023
Q2 		$9.63K Buy
+179
New +$7.93K ﹤0.01% 1558

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

First Horizon Advisors's ANIP Position: Q2 2025 in Review

First Horizon Advisors sold out of ANI Pharmaceuticals (ANIP) in Q2 2025, closing a stake of 160 shares — an estimated $10.7K sold.

First Horizon Advisors first reported a position in ANIP in Q2 2023 and held it in 6 quarters. The position peaked at $10.7K in Q1 2025. 232 funds tracked by Wall St. Rank hold ANIP as of Q2 2025.

  • First Horizon Advisors reported no remaining ANI Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • First Horizon Advisors sold 160 ANI Pharmaceuticals shares in Q2 2025, an estimated $10.7K.
  • First Horizon Advisors first reported a position in ANI Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • First Horizon Advisors's ANI Pharmaceuticals position peaked at $10.7K in Q1 2025.
  • 232 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.